pfizer

🚨 Pfizer beats earnings expectations on both fronts! Full-year revenue could reach $64 billion—can pharma stocks become a safe haven for capital? 💊📈🔥

🇺🇸 On 11/3, Pfizer (PFE) reported its third-quarter results! Revenue and EPS both beat Wall Street expectations, and full-year guidance was raised!

📊 ① Earnings report
🟢 Revenue: $16.583 billion
📈 Market expectation: about $15.87 billion
🟢 Adjusted EPS: $0.87
📈 Market expectation: $0.73
💰 Net income: about $3.242 billion
⚠️ Revenue was nearly flat year over year, while net income fell about 8%. Results were impressive, but concerns remain!

💊 ② Which businesses are growing?
🚀 Revenue from newly launched and acquired products: up 32% year over year
🟢 Eliquis: up 25% year over year
🟢 Padcev: up 55% year over year
🟢 Revenue excluding COVID products: up 7%
The growth rates above are calculated on a constant-currency basis.

🔴 ③ COVID products continue to decline
📉 Paxlovid revenue: down 63% year over year
📉 Comirnaty vaccine: down 29% year over year
Pfizer is reducing its reliance on COVID products and shifting toward cancer, obesity, and other new-drug markets.

💰 ④ Full-year guidance raised!
🟢 Full-year revenue forecast: $62–64 billion
🟢 Adjusted EPS: $2.95–3.05
This signals greater confidence from management in the company’s performance ahead!

🌍 ⑤ What could this mean for U.S. stocks, BTC, and ETH?
🏦 If capital shifts from high-valuation tech stocks to pharmaceutical stocks, it could reflect declining market risk appetite.
📉 But a rise in pharmaceutical stocks does not necessarily mean BTC and ETH will fall.
🔍 Keep watching tech stocks, the U.S. dollar, Treasury yields, and capital flows.

🎯 My take
The biggest highlight this time wasn’t just Pfizer beating earnings expectations—it was the gradual shift toward new-drug businesses taking over from COVID products.

As tech stocks face pressure over AI valuations, whether capital will rotate into defensive industries with stable earnings is worth watching!

🔥 The essence of trading and investing isn’t to chase the market with the biggest gains forever. It’s about recognizing where the next opportunity may emerge as capital rotates!
$BTC
$ETH
$HYPE
#pfizer

Which is your favorite stock?
Drop comments👇

$MELI
$PFE
$OXY
👍👍 dyor
#binancesquare #pfizer

$PFE USDT – Pfizer
Pfizer is currently trading at $30.45, down 0.46%. The movement is relatively small, showing a mild pullback. It will be interesting to see whether buyers step in and support the price.

$PFE
#Write2Earrn #PFEUSDT #Pfizer #MarketUpdate #TradingSignal